Oral and Topical Centella asiatica in Type 2 Diabetes Mellitus Patients with Dry Skin: A Three-Arm Prospective Randomized Double-Blind Controlled Trial
Table 3
Comparison of SRRC, percentage of SRRC decrement, and SCap subgroup analysis in well-controlled blood glucose subjects.
Parameter
CAo + CAt
Plo + CAt
Plo + Plt
value
SRRC
D 1
0.14
n
18
16
21
Median (min–max)
4 (3–10)
5 (3–7)
5 (3–8)
D 15
0.77
n
20
18
18
Median (min–max)
2 (0–6)
2.5 (0–4)
2 (0–7)
D 29
0.12
n
20
17
18
Median (min–max)
1 (0–5)
2 (0–5)
2 (0–6)
Percentage of SRRC decrement
D 15
0.55
n
20
18
18
Median (min–max)
50 (0–100)
50 (0–100)
33.3 (0–100)
D 29
0.11
n
20
17
18
Median (min–max)
75 (16.7–100)a
60 (0–100)
50 (14.3–100)
SCap (AU)
D 1
0.30
n
18
16
21
Median (min–max)
27.9 (15.6–36.4)
24.3 (15–32.7)
25.9 (13.8–46)
D 15
0.36
n
20
18
18
Median (min–max)
40.5 (21.1–51.6)
38.1 (21.8–58.5)
36.1 (21.5–59.9)
D 29
0.03
n
20
17
18
Median (min–max)
47 (30.7–61.3)a
45.6 (20.1–15.5)
38.5 (19.7–53.4)
Kruskal–Wallis test amongst three groups, followed by the Mann–Whitney test, to assess the difference between each group. aCompared to Plo + Plt with .
